Growth Metrics

NovoCure (NVCR) EBT Margin Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -419.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 110.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -300.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -287.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 233.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 772.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -464.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 584.00
10 NovoCure 1.90 Bn 1.47 Bn 135.13 Mn -2,024.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,024.00
Dec 31, 2025 1,074.00
Sep 30, 2025 -404.00
Jun 30, 2025 -691.00
Mar 31, 2025 330.00
Dec 31, 2024 -543.00
Sep 30, 2024 2,396.00
Jun 30, 2024 2,765.00
Mar 31, 2024 1,896.00
Dec 31, 2023 -345.00
Sep 30, 2023 -2,000.00
Jun 30, 2023 -2,618.00
Mar 31, 2023 -3,998.00
Dec 31, 2022 -615.00
Sep 30, 2022 -999.00
Jun 30, 2022 -667.00
Mar 31, 2022 20.00
Dec 31, 2021 -2,533.00
Sep 30, 2021 -1,620.00
Jun 30, 2021 -1,341.00
Mar 31, 2021 368.00
Dec 31, 2020 773.00
Sep 30, 2020 691.00
Jun 30, 2020 354.00
Mar 31, 2020 587.00
Dec 31, 2019 1,393.00
Sep 30, 2019 1,321.00
Jun 30, 2019 1,612.00
Mar 31, 2019 2,205.00
Dec 31, 2018 -270.00
Sep 30, 2018 431.00
Jun 30, 2018 2,999.00
Mar 31, 2018 1,172.00
Dec 31, 2017 -21,204.00
Sep 30, 2017 12,439.00
Jun 30, 2017 16,475.00
Mar 31, 2017 20,353.00
Dec 31, 2016 45,342.00
Sep 30, 2016 13,925.00
Jun 30, 2016 21,829.00
Mar 31, 2016 18,385.00
Dec 31, 2015 -118,090.00
Sep 30, 2015 13,080.00